• HOME
  • Welcome Greeting
  • Outline
  • To Presenters
  • General Information for Participants
  • Registration (Early Bird)
  • Registration (On-site)
  • Call for Abstracts
  • Program
  • Accepted Regular Abstracts
  • Travel Grant
  • Guide for the YIA for International Students
  • Sponsored Seminars
  • Venue & Access
  • Hotel Accommodation
  • Links
Medtronic Academy
Kyoto Meetings Industry Information
JAPANESE ENGLISH

The 84th Annual Scientific Meeting of the Japanese Circulation Society Congress Chairperson:Takeshi Kimura, M.D., Ph.D.(Professor, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto) Date:March 13 (Fri.) -15 (Sun.), 2020 Kyoto International Conference Center Grand Prince Hotel The 84th Annual Scientific Meeting of the Japanese Circulation Society

Sponsored Seminars

* Luncheon seminar reservation is only available for English Seminar.

Luncheon Seminar

Luncheon Seminar 1

Thursday, March 12, 2020, 12:20~13:10 Room A, 2F, Kyoto International Conference Center

English

Non-invasive FFRCT - Considering appropriate non-invasive cardiac testing -
Co-sponsor: HeartFlow Japan G.K.

Luncheon Seminar 2

Thursday, March 12, 2020, 12:20~13:10 Room K, 2F, Kyoto International Conference Center
How ivabradine works in the treatment of heart failure with reduced ejection fraction?
Co-sponsor: ONO PHARMACEUTICAL CO., LTD.

Luncheon Seminar 3

Thursday, March 12, 2020, 12:20~13:10 Room C-1, 1F, Kyoto International Conference Center

English

Cardiovascular Prevention in Middle Income Countries of Asia
Co-organizer: Japan Cardiovascular Association (JCVA)

Luncheon Seminar 4

Thursday, March 12, 2020, 12:20~13:10 Room C-2, 1F, Kyoto International Conference Center

English

Stroke prevention in atrial fibrillation: Perspectives from Asia
Co-sponsor: Bristol-Myers Squibb / Pfizer Japan Inc.

Luncheon Seminar 5

Thursday, March 12, 2020, 12:20~13:10 Room D, 1F, Kyoto International Conference Center
The Clinical Implication of Intensive Lipid lower treatment for ACS
Co-sponsor: Sanofi K.K.

Luncheon Seminar 6

Thursday, March 12, 2020, 12:20~13:10 Room E, B1F, Kyoto International Conference Center

English

Decongestion therapy in acute heart failure : based on real world
Co-sponsor: Otsuka Pharmaceutical Co.,Ltd.

Luncheon Seminar 72

Thursday, March 12, 2020, 12:20~13:10 Room I, 2F, Kyoto International Conference Center

English

APSC Consensus Statement Lunch Symposium 1
Co-sponsor: Asian Pacific Society of Cardiology Congress

Luncheon Seminar 73

Thursday, March 12, 2020, 12:20~13:10 Room J, 2F, Kyoto International Conference Center
The Forefront of ICT Utilization on the Field of Cardiology in Japan
Co-sponsor: MID, Co.,Ltd.

Luncheon Seminar 7

Friday, March 13, 2020, 13:00~13:50 Room A, 2F, Kyoto International Conference Center
Consensus of congestion treatment for heart failure considering cardio-renal syndrome
Co-sponsor: Otsuka Pharmaceutical Co.,Ltd.

Luncheon Seminar 8

Friday, March 13, 2020, 13:00~13:50 Room B-1, 2F, Kyoto International Conference Center

English

Plaque Imaging for Clinical Practice
Co-sponsor: Kowa Company, Ltd.

Luncheon Seminar 9

Friday, March 13, 2020, 13:00~13:50 Room B-2, 2F, Kyoto International Conference Center
Biophysics of RF Ablation: New Ablation Modalities to Optimize RF Energy Delivery in AF Ablation
Co-sponsor: Johnson & Johnson K.K. Medical Company

Luncheon Seminar 10

Friday, March 13, 2020, 13:00~13:50 Room C-1, 1F, Kyoto International Conference Center
Mineralocorticoid receptor-associated hypertension and its organ damage
Co-sponsor: Daiichi Sankyo Co.,Ltd.

Luncheon Seminar 11

Friday, March 13, 2020, 13:00~13:50 Room C-2, 1F, Kyoto International Conference Center
The Significance of BNP-test for the Imminent Upsurge of Elderly Heart Failure - Responding to the Establishment of Basic Control Act -
Co-sponsor: SHIONOGI & CO., LTD. / Tosoh Corporation/LSI Medience Corporation/SEKISUI MEDICAL CO.,LTD. / FUJIREBIO INC.

Luncheon Seminar 12

Friday, March 13, 2020, 13:00~13:50 Room D, 1F, Kyoto International Conference Center
Acute Kidney Injury in Medical Cardiac Intensive Care Units:Clinical Significance of Measurements of Urinary L-FABP Concentration
Co-sponsor: CMIC HOLDINGS Co., Ltd. / SEKISUI MEDICAL CO., LTD.

Luncheon Seminar 13

Friday, March 13, 2020, 13:00~13:50 Room E, B1F, Kyoto International Conference Center

English

Anticoagulation for Venous Thromboembolism 2020:-Recent progress, Remaining Challenges-
Co-sponsor: Bayer Yakuhin, Ltd.

Luncheon Seminar 14

Friday, March 13, 2020, 13:00~13:50 Room I, 2F, Kyoto International Conference Center
APSC Consensus Statement Lunch Symposium 2
Use of High Sensitivity Troponin Assays
Co-sponsor: Asian Pacific Society of Cardiology Congress

Luncheon Seminar 15

Friday, March 13, 2020, 13:00~13:50 Room J, 2F, Kyoto International Conference Center
Treatment Strategy for Pulmonary Artery Hypertension
~Effects and Limitations of Oral Medical Treatment~
Co-sponsor: NIPPON SHINYAKU CO., LTD. / Actelion Pharmaceuticals Japan Ltd.

Luncheon Seminar 16

Friday, March 13, 2020, 13:00~13:50 Room K, 2F, Kyoto International Conference Center
The up-to-date diagnosis of syncope and arrhythmia treatment from the viewpoint of guidelines
Co-sponsor: Medtronic Japan Co., Ltd.

Luncheon Seminar 17

Friday, March 13, 2020, 13:00~13:50 Swan, B1F, Kyoto International Conference Center

English

New Evidence of Comprehensive Cardiovascular Risk Management
Co-sponsor: Fukuda Denshi Co., Ltd.

Luncheon Seminar 18

Friday, March 13, 2020, 13:00~13:50 Annex Hall 1, 1F, Kyoto International Conference Center
How could we manage residual risk of coronary heart diseases?
Co-sponsor: Takeda Pharmaceutical Company Limited

Luncheon Seminar 19

Friday, March 13, 2020, 13:00~13:50 Annex Hall 2, 1F, Kyoto International Conference Center
For Safe and Speedy Procedure of Atrial Fibrillation
Co-sponsor: Abbott Medical Japan LLC

Luncheon Seminar 20

Friday, March 13, 2020, 13:00~13:50 Room 501, 5F, Kyoto International Conference Center
Guideline of Diabetes Therapy for Cardiovascular Prevention ~ from JDS, JCS Joint Statement~
Co-sponsor: MSD K.K. / Astellas Pharma Inc. / Kotobuki pharmaceutical Co., Ltd.

Luncheon Seminar 21

Friday, March 13, 2020, 13:00~13:50 Room 510, 5F, Kyoto International Conference Center
Cancer Associated Thrombosis
Co-sponsor: DAIICHI SANKYO Co., Ltd.

Luncheon Seminar 22

Friday, March 13, 2020, 13:00~13:50 Room 555, 5F, Kyoto International Conference Center
Closing in on the pathophysiology of cardiorenal syndrome
~Impact of Indoxyl sulfate in cardio-renal interaction~
Co-sponsor: Mitsubishi Tanabe Pharma Corporation

Luncheon Seminar 23

Friday, March 13, 2020, 13:00~13:50 Room 554, 5F, Kyoto International Conference Center
Changes in Pulmonary Hypertension Medical Care
~Yesterday, Today, and Tomorrow~
Co-sponsor: Mochida Pharmaceutical Co., Ltd.

Luncheon Seminar 24

Friday, March 13, 2020, 13:00~13:50 Sakura, B1F, Kyoto International Conference Center

English

Clinical Outcome Endoscopically Guided Ablation System in Japan and Clinical Update of Europe
Co-sponsor: Japan Lifeline Co., Ltd.

Luncheon Seminar 25

Friday, March 13, 2020, 13:00~13:50 Prince Hall 1, B2F, Grand Prince Hotel Kyoto
The importance of cardiovascular and respiratory disease control in the elderly
Co-sponsor: Pfizer Japan Inc.

Luncheon Seminar 26

Friday, March 13, 2020, 13:00~13:50 Prince Hall 2, B2F, Grand Prince Hotel Kyoto

English

NOACs in atrial fibrillation: From Clinical Trials to Real World practice
Co-sponsor: Bristol-Myers Squibb / Pfizer Japan Inc.

Luncheon Seminar 27

Friday, March 13, 2020, 13:00~13:50 Gold Room, B2F, Grand Prince Hotel Kyoto
Clinical Update on Pharmacotherapy of Atrial Fibrillation - Based on New Guidelines for Drug Treatment of Arrhythmias -
Co-sponsor: TOA EIYO LTD.

Luncheon Seminar 28

Friday, March 13, 2020, 13:00~13:50 Rose Room, B1F, Grand Prince Hotel Kyoto

English

Positioning of SGLT2 inhibitors in Type 2 Diabetes Treatment
Co-sponsor: ONO PHARMACEUTICAL CO., LTD. / AstraZeneca K.K.

Luncheon Seminar 29

Friday, March 13, 2020, 13:00~13:50 Royal Room, 1F, Grand Prince Hotel Kyoto
How to select the best SAVR valves by Heart Team
Co-sponsor: Abbott Medical Japan LLC

Luncheon Seminar 30

Saturday, March 14, 2020, 13:00~13:50 Room A, 2F, Kyoto International Conference Center

English

New Horizons of Residual Cardiovascular Risk
Co-sponsor: Kowa Company, Ltd.

Luncheon Seminar 31

Saturday, March 14, 2020, 13:00~13:50 Room B-1, 2F, Kyoto International Conference Center

English

The essence of the latest CRT guideline
Co-sponsor: Medtronic Japan Co.,Ltd.

Luncheon Seminar 32

Saturday, March 14, 2020, 13:00~13:50 Room B-2, 2F, Kyoto International Conference Center
Let's Think About siRNA
Co-sponsor: Alnylam Japan K.K.

Luncheon Seminar 33

Saturday, March 14, 2020, 13:00~13:50 Room C-1, 1F, Kyoto International Conference Center
Comprehensive management of dyslipidemia
Co-sponsor: Mochida Pharmaceutical Co., Ltd.

Luncheon Seminar 34

Saturday, March 14, 2020, 13:00~13:50 Room C-2, 1F, Kyoto International Conference Center

English

ATTR amyloidosis. Where are these patients?
Co-sponsor: Pfizer Japan Inc.

Luncheon Seminar 35

Saturday, March 14, 2020, 13:00~13:50 Room D, 1F, Kyoto International Conference Center

English

Impella Heart Pump
Hemodynamic Support and Acute Cardiac Unloading for HEART RECOVERY
Co-sponsor: Abiomed Japan K.K.

Luncheon Seminar 36

Saturday, March 14, 2020, 13:00~13:50 Room E, B1F, Kyoto International Conference Center

English

Secondary stroke prevention with PFO closure -For successful introduction to Japan learning from global experience-
Co-sponsor: Abbott Medical Japan LLC

Luncheon Seminar 37

Saturday, March 14, 2020, 13:00~13:50 Room I, 2F, Kyoto International Conference Center
Know diabetic heart disease by the “CVOTs” -Worth revisiting glucagon-
Co-sponsor: MSD K.K.

Luncheon Seminar 38

Saturday, March 14, 2020, 13:00~13:50 Room J, 2F, Kyoto International Conference Center
Potentiality of diagnostic imaging in clinical practice for patients with Fabry disease
Co-sponsor: JCR Pharmaceuticals Co., Ltd.

Luncheon Seminar 39

Saturday, March 14, 2020, 13:00~13:50 Room K, 2F, Kyoto International Conference Center
How Can We Help Constipation Patients Have Natural Bowel Movement?
Co-sponsor: Mylan EPD G.K.

Luncheon Seminar 40

Saturday, March 14, 2020, 13:00~13:50 Swan, B1F, Kyoto International Conference Center

English

IMPACT of WATCHMAN : for Your Patients, for Your Strategy, for the World
Co-sponsor: Boston Scientific Japan K.K.

Luncheon Seminar 41

Saturday, March 14, 2020, 13:00~13:50 Annex Hall 1, 1F, Kyoto International Conference Center
Do you use metformin in diabetes patients with a high risk for heart failure?
Co-sponsor: Takeda Pharmaceutical Company Limited

Luncheon Seminar 42

Saturday, March 14, 2020, 13:00~13:50 Annex Hall 2, 1F, Kyoto International Conference Center
All You Need to Know about the Guideline Update ~Treatment of Aortic Stenosis for Today~
Co-sponsor: Edwards Lifesciences Ltd.

Luncheon Seminar 43

Saturday, March 14, 2020, 13:00~13:50 Room 501, 5F, Kyoto International Conference Center
2019 JCS, AHA/ACC, and ESC/EAS Guidelines for the management of dyslipidaemias: New Topic Llipid Modification to Reduce Cardiovascular Events
Co-sponsor: MSD K.K. / Bayer Yakuhin, Ltd.

Luncheon Seminar 44

Saturday, March 14, 2020, 13:00~13:50 Room 555, 5F, Kyoto International Conference Center
Investigate the cause of cardiopathy -Fabry disease-
Co-sponsor: Sumitomo Dainippon Pharma Co., Ltd.

Luncheon Seminar 45

Saturday, March 14, 2020, 13:00~13:50 Sakura, B1F, Kyoto International Conference Center
A new enlightenment of diagnostic ultrasound system
Co-sponsor: CANON MEDICAL SYSTEMS CORPORATION

Luncheon Seminar 46

Saturday, March 14, 2020, 13:00~13:50 Prince Hall 1, B2F, Grand Prince Hotel Kyoto

English

Anticoagulant Therapy for VTE: The New Paradigm of Risk-Benefit
Co-sponsor: Bristol-Myers Squibb / Pfizer Japan Inc.

Luncheon Seminar 47

Saturday, March 14, 2020, 13:00~13:50 Prince Hall 2, B2F, Grand Prince Hotel Kyoto
Anticoagulant Therapy for Atrial Fibrillation Patients with High Risk: from Prospective trials in Japanese
Co-sponsor: Bayer Yakuhin, Ltd.

Luncheon Seminar 48

Saturday, March 14, 2020, 13:00~13:50 Gold Room, B2F, Grand Prince Hotel Kyoto
Clinical significance of intensive lipid-lowering therapy and my expectation for PCSK9 inhibitor
Co-sponsor: Astellas Pharma Inc. / Amgen Astellas BioPharma K.K.

Luncheon Seminar 49

Saturday, March 14, 2020, 13:00~13:50 Rose Room, B1F, Grand Prince Hotel Kyoto

English

Strategy for Heart Failure with Atrial Fibrillation
Co-sponsor: Johnson and Johnson K.K. Medical Company

Luncheon Seminar 50

Saturday, March 14, 2020, 13:00~13:50 Royal Room, 1F, Grand Prince Hotel Kyoto
Precision Medicine of Coronary Artery Diseases
Co-sponsor: Nippon Boehringer Ingelheim Co., Ltd.

Luncheon Seminar 51

Sunday, March 15, 2020, 13:00~13:50 Room A, 2F, Kyoto International Conference Center
GLP-1 receptor agonists for the treatment of T2DM and management of CVD
Co-sponsor: Novo Nordisk Pharma Ltd. CMR development Div. Medical Affairs Department

Luncheon Seminar 52

Sunday, March 15, 2020, 13:00~13:50 Room B-1, 2F, Kyoto International Conference Center
Challenging Issues of TAVI   - PCI after TAVI, Conduction Defects, and Durability –
Co-sponsor: Medtronic Japan Co.,Ltd.

Luncheon Seminar 53

Sunday, March 15, 2020, 13:00~13:50 Room B-2, 2F, Kyoto International Conference Center
New treatment of heart failure by Kampo medicine
~Tips on using Risuizai~
Co-sponsor: Tsumura&Co.

Luncheon Seminar 54

Sunday, March 15, 2020, 13:00~13:50 Room C-1, 1F, Kyoto International Conference Center
Gastrointestinal disorders that cardiologists should be aware of ~ Constipation is boring but important ~
Co-sponsor: Astellas Pharma Inc.

Luncheon Seminar 55

Sunday, March 15, 2020, 13:00~13:50 Room C-2, 1F, Kyoto International Conference Center
PAH treatment strategy to improve long-term survival
Co-sponsor: Actelion Pharmaceuticals Japan Ltd. / NIPPON SHINYAKU CO., LTD.

Luncheon Seminar 56

Sunday, March 15, 2020, 13:00~13:50 Room D, 1F, Kyoto International Conference Center
MitraClip® from the latest evidence  – 100,000 patients treated with MitraClip® -
Co-sponsor: Abbott Vascular Japan Co., Ltd.

Luncheon Seminar 57

Sunday, March 15, 2020, 13:00~13:50 Room E, B1F, Kyoto International Conference Center
Treatment of type 2 diabetes from the viewpoint of cardiologist
Co-sponsor: Mitsubishi Tanabe Pharma Corporation / DAIICHI SANKYO COMPANY, LIMITED

Luncheon Seminar 58

Sunday, March 15, 2020, 13:00~13:50 Room J, 2F, Kyoto International Conference Center
Updated aggressive treatment for PAH 2020
Co-sponsor: Bayer Yakuhin, Ltd.

Luncheon Seminar 59

Sunday, March 15, 2020, 13:00~13:50 Room K, 2F, Kyoto International Conference Center
Diabetes Treatment from the point of view of a cardiologist
~ Saving insulin secretion with metformin ~
Co-sponsor: Sumitomo Dainippon Pharma Co., Ltd.

Luncheon Seminar 60

Sunday, March 15, 2020, 13:00~13:50 Swan, B1F, Kyoto International Conference Center
The renovation of the long time ECG monitoring strategy
Co-sponsor: Fukuda Denshi Co., Ltd.

Luncheon Seminar 61

Sunday, March 15, 2020, 13:00~13:50 Annex Hall 1, 1F, Kyoto International Conference Center
Hypertensive phenotype (Isolated diastolic hypertension): Clinical practice on the basis of pathophysiology and The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH2019)
Co-sponsor: Takeda Pharmaceutical Company Limited

Luncheon Seminar 62

Sunday, March 15, 2020, 13:00~13:50 Room 501, 5F, Kyoto International Conference Center
Treatment Strategies for Sleep Disorders Breathing in Heart Failure ~thinking by heart failure stage~
Co-sponsor: TEIJIN PHARMA LIMITED / ResMed Limited

Luncheon Seminar 63

Sunday, March 15, 2020, 13:00~13:50 Room 510, 5F, Kyoto International Conference Center
Ultrastructural Endothelial Injury and Antithrombin
Co-sponsor: Japan Blood Products Organization

Luncheon Seminar 64

Sunday, March 15, 2020, 13:00~13:50 Room 555, 5F, Kyoto International Conference Center
A Practical Approach to Diagnosis of Fabry Disease and Mucopolysaccharidosis in Cardiovascular Medicine
Co-sponsor: Sanofi K.K.

Luncheon Seminar 65

Sunday, March 15, 2020, 13:00~13:50 Room 554, 5F, Kyoto International Conference Center
Utilization of imaging modality in diagnosis of Chronic Coronary Syndrome(CCS)
Co-sponsor: Japanese Society of Nuclear Cardiology / FUJIFILM Toyama Chemical Co., LTD.

Luncheon Seminar 66

Sunday, March 15, 2020, 13:00~13:50 Sakura, B1F, Kyoto International Conference Center
Cardiovascular disease at the time of disaster:Changes over time of disaster-related diseases and necessary tests
-Examining the heart with biomarkers-
Co-sponsor: Ortho Clinical Diagnostics Japan

Luncheon Seminar 67

Sunday, March 15, 2020, 13:00~13:50 Prince Hall 1, B2F, Grand Prince Hotel Kyoto
Prognostic Relevance of Heart Rate in Heart Failure
Co-sponsor: ONO PHARMACEUTICAL CO., LTD.

Luncheon Seminar 68

Sunday, March 15, 2020, 13:00~13:50 Prince Hall 2, B2F, Grand Prince Hotel Kyoto

English

SGLT2i and Cardiorenal Protection for T2DM: A mechanistic and clinical perspective
Co-sponsor: Nippon Boehringer Ingelheim Co., Ltd. / Eli Lilly Japan K.K.

Luncheon Seminar 69

Sunday, March 15, 2020, 13:00~13:50 Gold Room, B2F, Grand Prince Hotel Kyoto
Current status of combination therapy and future treatment strategies in Japanese patients with pulmonary arterial hypertension
Co-sponsor: GlaxoSmithKline K.K.

Luncheon Seminar 70

Sunday, March 15, 2020, 13:00~13:50 Rose Room, B1F, Grand Prince Hotel Kyoto
Appropriate screening, precise diagnosis and novel therapeutic intervention for cardiac amyloidosis
Co-sponsor: Pfizer Japan Inc.

Luncheon Seminar 71

Sunday, March 15, 2020, 13:00~13:50 Royal Room, 1F, Grand Prince Hotel Kyoto

English

How to implement results from evidence at DOACs ; Cardioversion, Catheter ablation and AF-PCI in clinical routine?
Co-sponsor: DAIICHI SANKYO CO., LTD.

Morning Seminar

Morning Seminar 7

Friday, March 13, 2020, 07:00~07:50 Room E, B1F, Kyoto International Conference Center

English

What do you think about diagnosis for stable coronary disease?
- Post ISCHEMIA Trail -
Co-sponsor: HeartFlow Japan G.K.

Morning Seminar 9

Friday, March 13, 2020, 07:00~07:50 Room K, 2F, Kyoto International Conference Center
Update on Large vessel vasculitis: pathophysiology, diagnosis and treatment
Co-sponsor: CHUGAI PHARMACEUTICAL CO., LTD.

Morning Seminar 41

Friday, March 13, 2020, 07:00~07:50 Room 554, 5F, Kyoto International Conference Center

English

Benefits of Lowering LDL-C with PCSK9i to Reduce Cardiovascular Event
Co-sponsor: Amgen Asia Holding Limited

Morning Seminar 28

Saturday, March 14, 2020, 07:00~07:50 Royal Room, 1F, Grand Prince Hotel Kyoto
Current diagnosis and treatment strategy of pulmonary hypertension
Co-sponsor: GlaxoSmithKline K.K.

Morning Seminar 40

Saturday, March 14, 2020, 07:00~07:50 Rose Room, B1F, Grand Prince Hotel Kyoto
Management of heart failure and integrated healthcare networks - Facing the heart failure pandemic-
Co-sponsor: Amgen Astellas BioPharma K.K.

Morning Seminar 42

Saturday, March 14, 2020, 07:00~07:50 Room J, 2F, Kyoto International Conference Center

English

Antithrombotic therapy in patients with AF and PCI or ACS
Co-sponsor: Bayer Yakuhin, Ltd.

Fireside Seminar

Fireside Seminar 1

Thursday, March 12, 2020, 18:40~20:40 Swan, B1F, Kyoto International Conference Center

English

【1】 18:40-19:30 Precision Medicine for Future Cardiovascular Pharmacotherapy
【2】 19:30-20:40 Tobacco Control in Western-Pacific Region 2020-2030
Co-organizer: Japan Cardiovascular Association (JCVA)

Fireside Seminar 2

Friday, March 13, 2020, 18:20~19:50 Room B-2, 2F, Kyoto International Conference Center
LAA Management for stroke prevention
Co-sponsor: Century Medical, Inc.

Fireside Seminar 4

Friday, March 13, 2020, 18:20~19:20 Swan, B1F, Kyoto International Conference Center
Anticoagulant therapy -Visiting old, Learn new-
Co-sponsor: Nippon Boehringer Ingelheim Co., Ltd.

Fireside Seminar 6

Friday, March 13, 2020, 18:40~19:40 Gold Room, B2F, Grand Prince Hotel Kyoto

English

Current trend of antiplatelet therapy in US and Japan
Co-sponsor: Terumo Corporation

Fireside Seminar 7

Saturday, March 14, 2020, 18:50~19:50 Room B-2, 2F, Kyoto International Conference Center
The role of MRA in the treatment of chronic heart failure
Co-sponsor: Pfizer Japan Inc.

Fireside Seminar 8

Saturday, March 14, 2020, 18:50~20:20 Room C-1, 1F, Kyoto International Conference Center
Sudden cardiac death management for ischemic and nonischemic heart failure by EPs
Co-sponsor: Asahi Kasei ZOLL Medical Corporation

Fireside Seminar 9

Saturday, March 14, 2020, 18:50~20:20 Room C-2, 1F, Kyoto International Conference Center

English

Cardio Pulmonary Coupling (CPC) - New Technology of Sleep Quality Measurement
Co-sponsor: MAGnet Ltd.

Fireside Seminar 10

Saturday, March 14, 2020, 18:50~20:20 Room D, 1F, Kyoto International Conference Center
Progress in the Research on Coronary Spasm -From Elucidation of Molecular Mechanism and Pathophysiology to International Collaboration Study
Co-sponsor: Japanese Coronary Spasm Association

Fireside Seminar 11

Saturday, March 14, 2020, 18:50~19:50 Room E, B1F, Kyoto International Conference Center
Current status and issues of the lipid-lowering therapy in acute coronary syndromes
Co-sponsor: Sanofi K.K.

Fireside Seminar 12

Saturday, March 14, 2020, 18:50~20:20 Swan, B1F, Kyoto International Conference Center
Antithrombotic Therapy Update ~Interpretation of new guidelines~
Co-sponsor: DAIICHI SANKYO Co., Ltd.

Fireside Seminar 13

Saturday, March 14, 2020, 18:50~20:50 Prince Hall 1, B2F, Grand Prince Hotel Kyoto

English

Responsible for global cardiovascular interventions - Evolution of catheter treatment, From DES to Watchman -
Co-sponsor: Boston Scientific Japan K.K.

Fireside Seminar 16

Saturday, March 14, 2020, 18:50~20:50 Royal Room, 1F, Grand Prince Hotel Kyoto
Change Practice!! For Japanese Patients with Coronary Artery Disease
Co-sponsor: Abbott Vascular Japan Co., Ltd.

Coffee Break Seminar

Coffee Break Seminar 1

Saturday, March 14, 2020, 15:40~16:30 Room B-1, 2F, Kyoto International Conference Center

English

Depth of the FROZEN -pursuing further possibilities of Cryoablation-
Co-sponsor: Medtronic Japan Co., Ltd.

Coffee Break Seminar 2

Saturday, March 14, 2020, 15:40~16:30 Room B-2, 2F, Kyoto International Conference Center
TAV in SAV: A Necessary Part of TAVI’s Future?
Co-sponsor: Medtronic Japan Co., Ltd.

Congress Secretariat :
c/o Congress Corporation
3-6-13 Awajimachi, Chuo-ku, Osaka 541-0047, Japan
Phone : +81-6-6233-9041 Fax : +81-6-6229-2556 E-mail : jcs2020@congre.co.jp